Drugs / bone marrow aspirate concentrate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02958267 | Dec 2016 → Aug 2018 | osteoarthritis, knee | OhioHealth | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow aspirate concentrate | “The study aimed to determine the clinical response to an autologous bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) intra-articular injection compared to...” PMID 34434003 ↗ Jan 2021 |
| Known as | BMAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02958267 ↗ |
| Route | Other | “Injection of bone marrow aspirate concentrate (BMAC) withdrawn from a bone near the hip into the knee joint (intra-articular) immediately followed by an injection of...” NCT02958267 ↗ |